6 questions covering the whole module, mixing recall with applied scenarios. Answer everything, then submit — you’ll see your score and every explanation at once. Pass threshold: 70%. Retake as many times as you like.
RecallQuestion 1
How does an RMP differ fundamentally from activities like coding, causality assessment, and signal detection?
RecallQuestion 2
What does RMP Part IV (PAES) specifically address, unlike every other part of the RMP?
ScenarioQuestion 3
A regulator requires a study specifically investigating whether a drug’s effectiveness holds up in patients with severe renal impairment, a population underrepresented in the original trials. Is this a PAES or a PASS?
RecallQuestion 4
Why does effectiveness evaluation of a risk minimisation measure need to assess both "process" and "outcome" separately?
ScenarioQuestion 5
A potential risk entered into an RMP at approval, based on preclinical data, is monitored for three years with no supporting evidence found. What is the appropriate outcome?
RecallQuestion 6
What is a key structural difference between a US REMS and an EU RMP?